Analytical and bioanalytical method validation of olaparib and tazemetostat by AQbD approach: supporting pre-clinical applications through in-silico modelling against breast cancer therapy

Microchemical Journal · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles